5 Hrs_1777294237270_124456903.png&w=64&q=75)
Source:
الوطن
Saudi-Korean Therapy Ties
The CEO of the Saudi Food and Drug Authority, Hisham Aljadhey, met with Korean companies in Seoul to discuss opportunities for collaboration in biotechnology and advanced therapies, as well as the exchange of research and regulatory expertise to facilitate the registration of innovative treatments and make them available to patients while ensuring their quality, safety, and efficacy. Aljadhey outlined the Authority’s regulatory pathways, including a pathway for attracting medicines for rare diseases. He also visited a Korean organization specializing in CAR T-cell therapies to explore opportunities for cooperation—supporting innovation in line with the Kingdom’s Biotechnology Strategy and Vision 2030.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)